Sun Pharmaceutical Industries Limited — Updates, 01-09-2026: Press Release
01-09-2026 | 01:50 am
01-09-2026 | 01:50 am
Sun Pharma committed to Most Favored Nation (MFN) pricing for US Medicaid and future innovative medicines. In return, it secured a two-year delay on Section 232 tariffs for innovative pharmaceutical products, aiding US patients and benefiting the company.
No comments yet. Be the first to comment!
All announcements from Sun Pharmaceutical Industries Limited
